GS-930: Began a Phase I study of the pro-drug GS-930 in 30 HIV-infected patient

Gilead Sciences Inc. (GILD), Foster City, Calif. Product: GS-930, pro-drug of cidofovir Indication: Cytomegalovirus (CMV) retinitis in AIDS Status: Began a Phase I study of the pro-drug GS-930 in 30 H...